# Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)

> **NCT06658522** · PHASE4 · RECRUITING · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 20 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension PAH
- Pulmonary Arterial Hypertension WHO Group I
- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Sotatercept

## Key facts

- **NCT ID:** NCT06658522
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-14
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06658522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06658522, "Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06658522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*